In recent years, we have seen a profusion of AI, algorithm, and machine-learning technologies enter clinical practice. This has happened across the health and care sector, and cancer testing and treatments have been no exception, with some proven benefits. For example, AI has been shown to be capable of recognising patterns in scan images that […]
Advanced radiotherapies: What are the challenges and opportunities?
Advanced radiotherapies are redefining the kinds of cancer treatment that are possible. These developments are exciting, but they also present new challenges. One challenge for researchers and clinicians is how to support policymakers, tasked with developing treatment and care standards across the NHS. So, what are these new treatments, what do they mean for patient […]
Access and inclusion: Can we move cancer services closer to home?
Traditionally, the vast majority of cancer services take place in hospitals, but new thinking and new technology are rapidly changing this landscape, particularly because of the impact of COVID-19 on the delivery of healthcare services. In this blog, from our On Cancer publication, Dr Philip Crosbie and Dr Dónal Landers outlines how delivering services at […]
Disadvantage and disease: finding solutions to inequalities in cancer
The COVID-19 pandemic has brought renewed focus to the great health inequalities between different communities in our society. Looking at cancer care, these inequalities exist across the whole cancer pathway from uptake in screening, likelihood to present early with symptoms, participation in clinical trials, diagnosis and access to treatments. In this blog, from our On […]
With great power: Taking responsibility for integrated care
July 2022 sees the formal establishment of the Integrated Care Systems (ICSs) created by the Health and Care Act 2022. These bodies will integrate health and social care in England, with the aim of providing more joined-up services tailored to local needs. However, questions remain about how ICSs will function at place-level, particularly in terms […]
Too close to the sun: The health benefits and economic case for banning sunbeds
Melanoma skin cancers are the UK’s fifth most common cancer, causing over 2,000 deaths each year. Over 85% of cases are preventable, with excessive exposure to ultraviolet light the most common cause, including the ultraviolet light used in sunbeds. The cancer risk from sunbeds is well known, but a new study has outlined the stark […]
Child of the North: Pregnancy and early years
Evidence makes it clear that exposure to adversity and stress has vast potential to negatively influence the trajectory of a person’s health and wellbeing throughout their life. In this blog, Professor Pamela Qualter and Dr Anna Sanders present the key findings of a Child of the North report, co-authored with colleagues from Newcastle, Bradford, Sheffield, […]
Antifungal resistance – a growing global problem
The spread of resistance to antifungal medications has led to many serious infections becoming untreatable, compromising patient safety and posing a global public health threat. The World Health Organisation (WHO) will soon publish its fungal pathogen priority list, highlighting fungi that are already untreatable, and those for which treatment outcomes are poor. In this blog, […]
Child of the North: Schools and education
COVID-19 exposed the disadvantage suffered by children and young people in our most deprived areas, disproportionately in the north of England. In this blog, Professor Caroline Bond and Professor Pamela Qualter discuss how these problems, and the accumulating evidence, demand a policy response. This is an adaptation of an article they co-authored for the Child […]
Rapid diagnosis and treatment of fungal infections
The rapid and accurate diagnosis of fungal infections is crucial to effective treatment and ultimately saves lives. Diagnostics are often not widely available in low income countries leading to inappropriate and delayed treatments. This is the case for a serious fungal infection called chronic pulmonary aspergillosis (CPA), and often for other fungal infections associated with […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 15
- Next Page »